Cita APA

Cheadle, E. J., Lipowska-Bhalla, G., Dovedi, S. J., Fagnano, E., Klein, C., Honeychurch, J., & Illidge, T. M. (2017). A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells. Leukemia.

Citación estilo Chicago

Cheadle, E J., G. Lipowska-Bhalla, S J. Dovedi, E. Fagnano, C. Klein, J. Honeychurch, y T M. Illidge. "A TLR7 Agonist Enhances the Antitumor Efficacy of Obinutuzumab in Murine Lymphoma Models Via NK Cells and CD4 T Cells." Leukemia 2017.

Cita MLA

Cheadle, E J., et al. "A TLR7 Agonist Enhances the Antitumor Efficacy of Obinutuzumab in Murine Lymphoma Models Via NK Cells and CD4 T Cells." Leukemia 2017.